DailyDoctor Archive Specialties Get app
Back to the 31 October 2026 edition

Clinical update · 01 of 06

Remimazolam TIVA: delirium no worse than propofol, less hypotension

Remimazolam-based TIVA was non-inferior to propofol for delirium after neurovascular surgery, with less hypotension and more early extubation.

Design
Randomised, double-blind, non-inferiority trial, single centre
Population
686 adults having elective neurovascular surgery
Primary outcome
Postoperative delirium within 5 days
Effect
12.8% vs 10.8% (difference 1.97 points, 95% CI −2.85 to 6.80)

In a single-centre, double-blind trial, 686 adults having elective neurovascular surgery — aneurysm clipping, AVM resection, microvascular decompression or bypass — received remifentanil with either remimazolam (reversed with flumazenil at emergence) or propofol.

Postoperative delirium within five days occurred in 12.8% with remimazolam and 10.8% with propofol (risk difference 1.97 points, 95% CI −2.85 to 6.80), meeting the 10-point non-inferiority margin. Hypotension below a MAP of 65 mmHg was much less with remimazolam (median burden 0 vs 7.5 mmHg·min), and more patients were extubated in theatre (85.2% vs 67.3%).

For TIVA during neuromonitoring, remimazolam is a reasonable alternative where haemodynamic stability matters. The caveat is the margin: delirium was rarer than the trial assumed, so a 10-point margin allows a relatively large excess to count as non-inferior.

  • Consider remimazolam-based TIVA where intraoperative hypotension is a particular concern
  • Plan flumazenil reversal at emergence if using remimazolam, as in the trial
  • Screen for delirium twice daily for several days after neurosurgery, whichever agent is used
  • Weigh local cost and availability of remimazolam against the haemodynamic benefit

Why it matters

It eases a key concern about using a benzodiazepine for maintenance in a delirium-prone population.

Don't overread it

With a generous margin and lower-than-expected delirium, a small increase in delirium cannot be excluded.

The statistics, in plain English

Non-inferior here means remimazolam was not worse by more than 10 percentage points. The observed upper limit was 6.8 points, which rules out a large excess but not a modest one — relevant when baseline delirium is about 11%.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

generalanaesperioperativeacutepainairwaymgmt

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app